About Our Product

Home / About

Oxy-Rx

(patented and previously FDA Approved, EMA registered)


Patent Family - Matinicus Pharma - London

More information on Oxy-Rx™ can be found below.

What is Oxy-Rx™?

Modified-Hemoglobin Protein Active Oxygen Carrier (m-HPAOC) s a safe, ultra-pure, effective, universally compatible, and rapidly deployed (RT Stable) material that provides tissue oxygentation via systematic OXYGEN "delivery".

What is Oxy-Rx™ designed to do?

Consistent, robust and reproducible supply, easy to store and transport with long shelf-life, universally compatible and readily available “fluid” oxygen support solution to preserve/sustain tissue perfusion and minimize cellular hypoxia and reverse ischemia​.

Opportunities

Licensing/collaborative opportunity for completed technological design and a documented “digital” operational package of a modular manufacturing facility for maintaining equivalency of biological products between sites and with harmonization with competent authority​.


m-HPAOC Key Characteristics


01

Modified & stabilized oxygen active proteins as an injectable solution​.

02

Chemically stabilized hemoglobin 7 g per 100 ml of bovine Hb (amino acid sequenced)​.

03

Manufactured as a purified extract from source-verified fresh drawn bovine blood.

04

Stabilized and packaged for long shelf live (5 years) at room temperature​.

05

Suitable for all blood types, no need of blood typing in case of emergencies.​

06

No Immunosuppression – invisible to the immune system.

07

Carrying Capacity - delivers oxygen within minute and halts acute-injury especially during a heart attack or stoke (tissue hypoxia).​

08

Size is 1/1000 of normal RBC, capable of supplying oxygen in cases of major blood vessel occlusion, constriction or low flow blood environments.​

09

Low viscosity (better circulation) for better perfusion at low pressures (limit or eliminate reperfusion injury)​.

10

Increasing Quality of Care – use during emergency and elective surgeries. ​

11

Advantages of a “Red Cell” Substitute (recreating the functionality of blood)​.

Two Critical Areas of Unmet Medical Needs and Opportunities with the Blood Supply

Systemic Oxygen Circulation and Delivery​

  • Hemodynamic and Blood Related

Metabolic Regulation

  • Cellular Function​
  • Blockage of the HIF pathway

Product Properties

  • Purity​
  • Reliability​
  • Stability​
  • Potency​
  • Low Immunogenicity​
  • Availability​
  • Quantity

© Matinicus Pharma  Site Made with ♥️ By Gossh Expert 2xN

For further information on OXY-Rx™ please contact us.

We would be happy to discuss it further.

0207 034 3300

We’d like to hear from you

Fitzrovia Hospital,

13-14 Fitzroy Square London, W1T 6AH

Please write to us

Contact us for further information

About

Matinicus Pharma provides life-sustaining support and resuscitation for local (tissue, organ) and systemic (body) oxygen deprivation.

Press Releases


Contact

0207 034 3300


Fitzrovia Hospital,

13-14 Fitzroy Square London, W1T 6AH